Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

…, TS Wachtmann, JP Umland… - Proceedings of the …, 2003 - National Acad Sciences
Prostaglandin (PG)E 2 is a potent mediator of pain and inflammation, and high levels of this
lipid mediator are observed in numerous disease states. The inhibition of PGE 2 production …

Development of a new permeability assay using low‐efflux MDCKII cells

L Di, C Whitney‐Pickett, JP Umland, H Zhang… - Journal of …, 2011 - Elsevier
Permeability is an important property of drug candidates. The Madin–Darby canine kidney
cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK …

Species independence in brain tissue binding using brain homogenates

L Di, JP Umland, G Chang, Y Huang, Z Lin… - Drug metabolism and …, 2011 - ASPET
Species independence of brain tissue binding was assessed with a large number of structurally
diverse compounds using equilibrium dialysis with brain homogenates of seven species …

Biarylcarboxylic Acids and -amides:  Inhibition of Phosphodiesterase Type IV versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the …

…, JS Pillar, JT Shirley, JP Umland… - Journal of medicinal …, 1996 - ACS Publications
In addition to having desirable inhibitory effects on inflammation, anaphylaxis, and smooth
muscle contraction, PDE-IV inhibitors also produce undesirable side effects including nausea …

Impact of recovery on fraction unbound using equilibrium dialysis

L Di, JP Umland, PE Trapa, TS Maurer - Journal of pharmaceutical …, 2012 - Elsevier
Historically, recovery had been used to evaluate the data quality of plasma protein binding or
tissue binding obtained from equilibrium dialysis assays. Low recovery was often indicative …

In vitro–in vivo extrapolation of key transporter activity at the blood–brain barrier

…, TS Maurer, NC Patel, MA West, JP Umland… - Drug Metabolism and …, 2019 - ASPET
Understanding the quantitative implications of P-glycoprotein and breast cancer resistance
protein efflux is a key hurdle in the design of effective, centrally acting or centrally restricted …

Strategic use of plasma and microsome binding to exploit in vitro clearance in early drug discovery

G Chang, SJ Steyn, JP Umland… - ACS Medicinal Chemistry …, 2010 - ACS Publications
Apparent intrinsic clearance (CLia) determined from microsomal stability assays is a
cornerstone in drug discovery. Categorical bins are routinely applied to this end point to facilitate …

GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF

WH Brissette, DA Baker, EJ Stam, JP Umland… - Cytokine, 1995 - Elsevier
Subcutaneous administration of Granulocyte-macrophage-colony stimulating factor (GM-CSF)
to mice enhanced LPS-induced cytokine production in the circulation (TNF, IL-6) and …

Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly …

…, JT Shirley, JE Tickner, JP Umland - Bioorganic & Medicinal …, 1995 - Elsevier
The synthesis and biological properties of a novel series of potent and selective
phosphodiesterase type IV (PDE IV) inhibitors are described. These catechol benzimidazoles were …

7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil Phosphodiesterase

…, KL Johnson, CR Turner, JP UmLand… - Journal of medicinal …, 1998 - ACS Publications
… lavage (BAL) was performed using one 15 mL wash of phosphate buffered saline (PBS)
delivered through a pediatric fiberoptic bronchoscope (Olympus, model BF 3C20, Japan) …